| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/30/1999 | WO1999048536A2 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
| 09/30/1999 | WO1999048535A1 Formulations for protection of peg-interferon alpha conjugates |
| 09/30/1999 | WO1999048532A1 Medicinal compositions adhering to stomach/duodenum |
| 09/30/1999 | WO1999048531A1 Remedies for hepatitis |
| 09/30/1999 | WO1999048519A1 Sustained-release preparation of physiologically active polypeptide and production thereof |
| 09/30/1999 | WO1999048517A1 Pharmaceutical compositions for prolonged peptide release and preparation method |
| 09/30/1999 | WO1999048506A2 Composition containing at least one metal yeast for pharmaceutical use and/or for use as a nutrition supplement, for humans or animals |
| 09/30/1999 | WO1999048499A1 Paroxetine compositions |
| 09/30/1999 | WO1999048498A1 Pharmaceutical formulation comprising a 2- [[(2- pyridinyl) methyl] sulfinyl] benzimidazole having anti-ulcer activity and a process for the preparation of such formulation |
| 09/30/1999 | WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis |
| 09/30/1999 | WO1999048494A1 Sustained-release composition of oxybutynin with reduced xerostomia effect |
| 09/30/1999 | WO1999048493A1 Transdermal therapeutic system (tts) containing oxybutynin |
| 09/30/1999 | WO1999048481A1 Coated donut-shaped tablets with long-term parabolic and zero-order release kinetics |
| 09/30/1999 | WO1999048480A2 Method for the production of micro capsules |
| 09/30/1999 | WO1999048479A1 Slow release microcapsules |
| 09/30/1999 | WO1999048478A1 Use of glycosaminoglycans degrading enzymes for management of airway associated diseases |
| 09/30/1999 | WO1999048477A1 Topical hormonal composition with systemic effect |
| 09/30/1999 | WO1999048476A1 Improved compositions for inhalation |
| 09/30/1999 | WO1999048475A1 Improved crystal structure |
| 09/30/1999 | WO1999048474A1 Pharmaceutical or cosmetic compositions containing photosensitizing substances |
| 09/30/1999 | WO1999048469A1 Composition for aroma delivery |
| 09/30/1999 | WO1999048379A1 Calcium-based chewy nougat formulation with magnesium |
| 09/30/1999 | WO1999048372A1 Encapsulation of components into edible products |
| 09/30/1999 | WO1999048361A1 Xylitol compositions for treating upper respiratory conditions |
| 09/30/1999 | WO1999042134A3 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders |
| 09/30/1999 | WO1999039741A3 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 09/30/1999 | WO1999038518A3 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation |
| 09/30/1999 | WO1999038506A3 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction |
| 09/30/1999 | WO1999038499A3 Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion |
| 09/30/1999 | WO1999038495A3 Controlled release delivery of peptide or protein |
| 09/30/1999 | WO1999037325A3 Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
| 09/30/1999 | WO1999033853A3 Carbohydrates, useful in solid delivery systems |
| 09/30/1999 | WO1999033492A9 Method for tissue perfusion |
| 09/30/1999 | DE19913864A1 DNA fragments useful for increasing p53 activity in a cell and reducing susceptibility to UV-induced hyperproliferative diseases |
| 09/30/1999 | DE19906034A1 High-purity squalane useful in cosmetic and pharmaceutical products, as vaccine adjuvant, for coating condoms and hypodermic needles, etc. |
| 09/30/1999 | DE19861012A1 Ophthalmological use of fluorocarbon with low dissolved oxygen content, e.g. for treating ischemic retinal disease |
| 09/30/1999 | DE19814014A1 Arzneipflanzentrockenextrakte Medicinal plant dry extracts |
| 09/30/1999 | DE19813773A1 Verfahren zur Herstellung von liposomalen Wirkstoffformulierungen Process for the preparation of liposomal drug formulations |
| 09/30/1999 | DE19812688A1 Solid dosage forms useful for slow release of drugs, fragrances, plant-treating agents, animal feed additives and food additives |
| 09/30/1999 | DE19812083A1 Simple preparation of coated particles, used to prepare systems for slow and/or targeted release of actives including pharmaceuticals, contrast agents, herbicides, pesticides, catalysts and pigments |
| 09/30/1999 | CA2325941A1 Calcium-based chewy nougat formulation with magnesium |
| 09/30/1999 | CA2325584A1 Improved compositions for inhalation |
| 09/30/1999 | CA2325554A1 Microcapsules having delayed release |
| 09/30/1999 | CA2325551A1 Improved crystal structure |
| 09/30/1999 | CA2325550A1 Remedies for hepatitis |
| 09/30/1999 | CA2325460A1 Azt derivatives exhibiting spermicidal and anti-viral activity |
| 09/30/1999 | CA2325420A1 Method for the production of microcapsules |
| 09/30/1999 | CA2325037A1 Composition for aroma delivery |
| 09/30/1999 | CA2324612A1 Paroxetine compositions |
| 09/30/1999 | CA2324568A1 Sustained-release preparation of physiologically active polypeptide and production thereof |
| 09/30/1999 | CA2324347A1 Benzoates derivatives for inhibiting angiogenesis |
| 09/30/1999 | CA2320387A1 Medicinal compositions adhering to stomach/duodenum |
| 09/30/1999 | CA2291066A1 Local delivery of long lasting therapeutic agents |
| 09/30/1999 | CA2233725A1 Hemoglobin-hydroxyethyl starch complexes |
| 09/29/1999 | EP0945137A1 Sustained-release pharmaceutical composition |
| 09/29/1999 | EP0945136A1 Pharmaceutical preparation comprising ciclosporin |
| 09/29/1999 | EP0945134A1 New galenic formulations of meloxicam for oral administration |
| 09/29/1999 | EP0945132A2 Ibuprofen composition |
| 09/29/1999 | EP0945131A1 Peroral drug suspension |
| 09/29/1999 | EP0945130A2 Use of alpha-omega substituted oxyalkylated silicones in cosmetics and pharmaceuticals |
| 09/29/1999 | EP0944675A1 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 09/29/1999 | EP0944398A1 Percutaneous delivery system |
| 09/29/1999 | EP0944397A1 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 09/29/1999 | EP0944384A1 Transdermal drug delivery system for the treatment of heart diseases |
| 09/29/1999 | EP0944383A1 Pharmaceutical suspension systems |
| 09/29/1999 | EP0944382A1 Methods and compounds for treatment of abnormal uterine bleeding |
| 09/29/1999 | EP0865274B1 Surface-stabilised pharmaceutical preparation for application on the skin |
| 09/29/1999 | EP0804146B1 Polyglycerine polyricinoleates |
| 09/29/1999 | EP0777468B1 Medical contact adhesive |
| 09/29/1999 | EP0776199B1 Oestradiol transdermal therapeutic system comprising hygroscopic additives |
| 09/29/1999 | EP0711140B1 Antifungal nail solution |
| 09/29/1999 | EP0642789B1 Remedy for glaucoma |
| 09/29/1999 | EP0630216B1 Adhesive bandage |
| 09/29/1999 | CN1230166A Illudin analogs useful as antitumor agents |
| 09/29/1999 | CN1230123A Inclusion complex containing indole selective serotonin agonist |
| 09/29/1999 | CN1230109A Process for producing solid dosage forms by extrusion |
| 09/29/1999 | CN1230108A Temp. sensitive gel for sustained delivery of protein drugs |
| 09/29/1999 | CN1229677A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/29/1999 | CN1229676A Human growth hormone-containing aqueous pharmaceutical composition |
| 09/29/1999 | CN1229664A Synergy tech. of normal cigarette for stopping cough, antiasthma and preventing cancer |
| 09/29/1999 | CN1229648A Biological cream and its prepn. method |
| 09/29/1999 | CN1229646A Method for prepn. of macromolecule microcapsule |
| 09/28/1999 | US5958979 Stabilized medicaments containing thyroid hormones |
| 09/28/1999 | US5958959 Administering 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)anilide or 2-cyano-3-hydroxy-n-(4-(trifluoromethyl)phenyl)-2-butenamide |
| 09/28/1999 | US5958937 Pharmaceutical formulations of poorly water soluble camptothecin analogues and NMP |
| 09/28/1999 | US5958921 Method for treating depression with olanzapine |
| 09/28/1999 | US5958915 Antibacterial composition for oral administration |
| 09/28/1999 | US5958911 Method of relieving inflammation by using 5-alkylsulfonylsalicylanilides |
| 09/28/1999 | US5958908 Sodium alendronate preparation for local administration |
| 09/28/1999 | US5958901 Delivery of anionic macromolecules into cells. |
| 09/28/1999 | US5958894 Complex with nucleic acid, cell entry, drug delivery |
| 09/28/1999 | US5958891 Administering vector comprising gene encoding dust mite allergen by intramuscular injection to prevent airway hyperreactivity or airway inflammation |
| 09/28/1999 | US5958876 Cyclosporin-containing pharmaceutical compositions |
| 09/28/1999 | US5958873 Oral formulation for treatment of bacteria-induced diseases of the colon |
| 09/28/1999 | US5958589 Starch-based microcellular foams |
| 09/28/1999 | US5958471 Product obtained by co-spray drying mixture of sorbitol, xylitol and mannitol dissolved in water, in air stream at elevated temperature |
| 09/28/1999 | US5958465 Apparatus for the production of drug-containing implants in the form of strings of beads |
| 09/28/1999 | US5958464 Liquid composition for preventing and treating milk fever in freshening cows, and a method of administering; basic composition is a mixture of water, calcium chloride, propylene glycol, b vitamins and minerals |
| 09/28/1999 | US5958463 Agricultural pesticide formulations |
| 09/28/1999 | US5958461 Vaginal pharmaceutical compositions |